Moritz Spangemacher

Dr. Moritz Spangemacher is a Physician Scientist and Doctoral Candidate at the Central Institute of Mental Health, Mannheim (ZI), affiliated with the Department of Molecular Neuroimaging and the Research Group Brain Stimulation. His work bridges clinical psychiatry, neuroimaging, and pharmacological interventions.

Research interests include psychedelic therapy, neuroinflammation, and non-invasive brain stimulation (e.g., rTMS). His recent publications focus on ketamine therapy for depression, clozapine metabolism, and the role of inflammatory biomarkers in psychiatric treatments. He adopts a salutogenic approach to mental health, emphasizing disease-modifying interventions.

His work spans psychopharmacology, neuroimmunology, and clinical psychiatry, with articles in journals like Lancet Psychiatry and Frontiers in Psychiatry. He contributes to understanding how immunological and molecular factors influence psychiatric therapies.